Baicalin |
HepG2 cells |
16 μM |
Pneumonia |
Inhibits NLRP3 inflammatory vesicles |
[128] |
Rat IEC-6 cells |
10.0 μg/mL |
Inflammatory bowel disease |
Inhibits IL-6 and TNF-α inflammatory factor levels |
[129] |
KOPN-8, RCH-ACV, SEM, RS4-11, NALM-6 |
10 mg/mL |
Acute B-lymphoblastic leukemia |
Inhibits the glycogen synthase kinase 3β and induces cell cycle arrest by upregulating p27Kip1 |
[130] |
MCF-7 and MDA-MB-231 cells |
30 μM |
Breast cancer |
Inhibits breast cancer cell proliferation and induces G1/S arrest in cells |
[131] |
Vero, BHK-21, and HEK 293T cells |
100 μM |
Chikungunya virus |
— |
[132] |
Baicalein and baicalin |
Vero CCL-81 cells |
20 μM |
SARS-CoV-2 |
Inhibits SARS-CoV-2 RNA-dependent RNA polymerase activity |
[105] |
Baicalein |
Vero E6 cell |
>2.0 μM |
COVID-19 |
Inhibits virus replication in vivo and reduces serum levels of IL-1β and TNF-α |
[133] |
Vero cell lines |
50 μM |
SARS-CoV-2 |
Inhibits SARS-CoV-2 replication and its 3C-like protease |
[105] |
HCT116 cells |
50 μM |
Colorectal cancer |
Induces apoptosis in human colon cancer cells |
[134] |
Silymarin |
Vero cells |
749.70 µg/mL |
Dengue virus |
Binds to the surface protein of the virus to prevent entry into the cell |
[70] |
Luteolin |
ARPE-19 cells |
50 μM |
Age-related macular degeneration |
Decreases levels of IL− 8 and IL− 6 |
[135] |
MDCK cells and Vero cells |
From 3.75 to 240 μM |
Influenza A virus |
Inhibits the expression of β-COP protein |
[136] |
Enzymatic inhibition assay |
4.6 μM |
COVID-19 |
Inhibits SARS-CoV-2 RNA-dependent RNA polymerase activity |
[25] |
EGCG |
Peripheral blood lymphocytes |
50 μM |
HIV |
— |
[137] |
live SARS-CoV-2 strain |
1 μg/mL |
SARS-CoV-2 |
Inhibits Nsp15 activity |
[111] |
E. coli
|
7.58 μg/ mL |
SARS-CoV-2 |
Inhibits the activity of 3CLpro
|
[112] |
Formononetin |
Vero cells |
14.91 μmol/L |
Enterovirus 71 |
Inhibits EV71-induced COX-2 expression and PGE2 production via MAPKs pathway |
[68] |
Biochanin A |
A549 cells |
5 μM |
H5N1 influenza A viruses |
Interferes with AKT, ERK 1/2, and NFκB activation to inhibit viral replication |
[65] |
Quercetin |
T-REx™-293 cell line |
10 μg/mL |
HCV |
Inhibits NS3 protease, thereby inhibiting viral replication |
[138] |
Naringenin |
Huh-7.5 cells |
25 μM |
HCV |
Reduces production of intracellular viral proteins |
[139] |